Genetic polymorphism of merozoite surface protein-3 in Myanmar Plasmodium falciparum field isolates.
Genetic diversity
Merozoite surface protein-3
Myanmar
Natural selection
Plasmodium falciparum
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
19 May 2020
19 May 2020
Historique:
received:
03
04
2020
accepted:
08
05
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
6
1
2021
Statut:
epublish
Résumé
Plasmodium falciparum merozoite surface protein-3 (PfMSP-3) is a target of naturally acquired immunity against P. falciparum infection and is a promising vaccine candidate because of its critical role in the erythrocyte invasion of the parasite. Understanding the genetic diversity of pfmsp-3 is important for recognizing genetic nature and evolutionary aspect of the gene in the natural P. falciparum population and for designing an effective vaccine based on the antigen. Blood samples collected from P. falciparum-infected patients in Naung Cho and Pyin Oo Lwin, Myanmar, in 2015 were used in this study. The pfmsp-3 was amplified by polymerase chain reaction, cloned, and sequenced. Genetic polymorphism and natural selection of Myanmar pfmsp-3 were analysed using the programs DNASTAR, MEGA6, and DnaSP 5.10.00. Genetic diversity and natural selection of the global pfmsp-3 were also comparatively analysed. Myanmar pfmsp-3 displayed 2 different alleles, 3D7 and K1. The 3D7 allelic type was predominant in the population, but genetic polymorphism was less diverse than for the K1 allelic type. Polymorphic characters in both allelic types were caused by amino acid substitutions, insertions, and deletions. Amino acid substitutions were mainly occurred at the alanine heptad repeat domains, whereas most insertions and deletions were found at the glutamate rich domain. Overall patterns of amino acid polymorphisms detected in Myanmar pfmsp-3 were similar in the global pfmsp-3 population, but novel amino acid changes were observed in Myanmar pfmsp-3 with low frequencies. Complicated patterns of natural selection and recombination events were predicted in the global pfmsp-3, which may act as major driving forces to maintain and generate genetic diversity of the global pfmsp-3 population. Global pfmsp-3 revealed genetic polymorphisms, suggesting that the functional and structural consequences of the polymorphisms should be considered in designing a vaccine based on PfMSP-3. Further examination of genetic diversity of pfmsp-3 in the global P. falciparum population is necessary to gain in-depth insight for the population structure and evolutionary aspect of global pfmsp-3.
Sections du résumé
BACKGROUND
BACKGROUND
Plasmodium falciparum merozoite surface protein-3 (PfMSP-3) is a target of naturally acquired immunity against P. falciparum infection and is a promising vaccine candidate because of its critical role in the erythrocyte invasion of the parasite. Understanding the genetic diversity of pfmsp-3 is important for recognizing genetic nature and evolutionary aspect of the gene in the natural P. falciparum population and for designing an effective vaccine based on the antigen.
METHODS
METHODS
Blood samples collected from P. falciparum-infected patients in Naung Cho and Pyin Oo Lwin, Myanmar, in 2015 were used in this study. The pfmsp-3 was amplified by polymerase chain reaction, cloned, and sequenced. Genetic polymorphism and natural selection of Myanmar pfmsp-3 were analysed using the programs DNASTAR, MEGA6, and DnaSP 5.10.00. Genetic diversity and natural selection of the global pfmsp-3 were also comparatively analysed.
RESULTS
RESULTS
Myanmar pfmsp-3 displayed 2 different alleles, 3D7 and K1. The 3D7 allelic type was predominant in the population, but genetic polymorphism was less diverse than for the K1 allelic type. Polymorphic characters in both allelic types were caused by amino acid substitutions, insertions, and deletions. Amino acid substitutions were mainly occurred at the alanine heptad repeat domains, whereas most insertions and deletions were found at the glutamate rich domain. Overall patterns of amino acid polymorphisms detected in Myanmar pfmsp-3 were similar in the global pfmsp-3 population, but novel amino acid changes were observed in Myanmar pfmsp-3 with low frequencies. Complicated patterns of natural selection and recombination events were predicted in the global pfmsp-3, which may act as major driving forces to maintain and generate genetic diversity of the global pfmsp-3 population.
CONCLUSION
CONCLUSIONS
Global pfmsp-3 revealed genetic polymorphisms, suggesting that the functional and structural consequences of the polymorphisms should be considered in designing a vaccine based on PfMSP-3. Further examination of genetic diversity of pfmsp-3 in the global P. falciparum population is necessary to gain in-depth insight for the population structure and evolutionary aspect of global pfmsp-3.
Identifiants
pubmed: 32429986
doi: 10.1186/s12936-020-03256-y
pii: 10.1186/s12936-020-03256-y
pmc: PMC7235555
doi:
Substances chimiques
Antigens, Protozoan
0
Protozoan Proteins
0
merozoite surface protein 3, Plasmodium
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
184Subventions
Organisme : National Research Foundation
ID : 2018M3A9H5055614
Organisme : National Research Foundation
ID : NRF-2019K1A3A9A01000005
Références
Malar J. 2009 Jul 17;8:163
pubmed: 19607731
J Infect Dis. 2002 Mar 1;185(5):657-64
pubmed: 11865423
Malar J. 2016 Oct 21;15(1):517
pubmed: 27769257
Mol Biochem Parasitol. 2009 Jun;165(2):153-61
pubmed: 19428662
Am J Trop Med Hyg. 2011 Feb;84(2):276-84
pubmed: 21292899
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
Malar J. 2017 Mar 16;16(1):119
pubmed: 28302168
Mol Biochem Parasitol. 1997 Aug;87(2):231-4
pubmed: 9247935
Mol Biochem Parasitol. 2009 Mar;164(1):45-56
pubmed: 19073223
Nat Med. 1996 Apr;2(4):437-42
pubmed: 8597954
Genetics. 1989 Nov;123(3):585-95
pubmed: 2513255
Am J Trop Med Hyg. 2009 Mar;80(3):479-86
pubmed: 19270302
PLoS Med. 2005 Nov;2(11):e344
pubmed: 16262450
Mol Biochem Parasitol. 1994 Nov;68(1):53-67
pubmed: 7891748
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Mol Biochem Parasitol. 1997 Dec 1;90(1):21-31
pubmed: 9497029
J Biol Chem. 2014 Feb 14;289(7):3856-68
pubmed: 24362023
Protein Sci. 2005 Jul;14(7):1778-86
pubmed: 15987906
PLoS One. 2011;6(7):e22525
pubmed: 21829466
Malar J. 2018 Oct 12;17(1):361
pubmed: 30314440
Malar J. 2018 Feb 07;17(1):71
pubmed: 29415731
Vaccine. 2009 Nov 16;27(49):6862-8
pubmed: 19755144
Vaccine. 2010 Sep 24;28(41):6698-703
pubmed: 20696154
Malar J. 2019 Jul 16;18(1):241
pubmed: 31311565
J Biol Chem. 2005 Nov 4;280(44):37236-45
pubmed: 16135515
Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:77-80
pubmed: 7565137
Jundishapur J Microbiol. 2014 May;7(5):e9829
pubmed: 25147718
J Infect Dis. 2013 Aug 1;208(3):479-88
pubmed: 23624363
Mol Biol Evol. 1986 Sep;3(5):418-26
pubmed: 3444411
Exp Parasitol. 2004 Nov-Dec;108(3-4):186-9
pubmed: 15582517
Parasite Immunol. 2007 Aug;29(8):387-94
pubmed: 17650180
Infect Immun. 2018 Jul 23;86(8):
pubmed: 29760216
Mol Biochem Parasitol. 2000 Jul;109(2):185-8
pubmed: 10960178
Korean J Parasitol. 2015 Apr;53(2):177-87
pubmed: 25925176
Parasit Vectors. 2018 Aug 6;11(1):455
pubmed: 30081943
Genetics. 1993 Mar;133(3):693-709
pubmed: 8454210